E. coli with engineered cell membranes have enhanced catalysis capabilities which reduce energy use and make production more sustainable.

Across India, at least 30 critically ill patients infected with multidrug-resistant (MDR) or extreme drug-resistant (XDR) bacteria that don’t respond to even last-line antibiotics — also called superb ...

A new study from the Manchester Institute of Biotechnology describes a novel biological method to convert mixed municipal ...

Cyanobacteria use an AM radio-like principle to coordinate cell division with circadian rhythms, encoding information through ...

A research team have recently published their article, "Rationally designed pooled CRISPRi-seq uncovers an inhibitor of ...

Researchers from the University of Illinois have reported complementary discoveries that will improve scientists' ...

GERMAN engineers have developed a biotechnological process to convert old wood waste into biohydrogen which can be used to ...

University scientists have developed a process using engineered bacteria to transform complex mixed waste into sustainable ...

The drug has been developed by Wockhardt with support from the Biotechnology Industry Research Assistance Council (BIRAC) and marketed as Miqnaf.

The development of an indigenous antibiotic Nafithromycin is an important achievement by Indian scientists, and may be ...